Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
The Symposium aims to present emerging discoveries in the field of lymphatic biology.
When and where:
Mon, 27 March 2023, 09:00 – 17:00 BST
Location:
The MRC Weatherall Institute of Molecular Medicine John Radcliffe Hospital Headington OX3 9DS United Kingdom
Guillermo Oliver, Northwestern University, USA:
Lymphangiocrine signaling in regeneration
Kari Alitalo, University of Helsinki, Finland:
Vascular growth factors
Tatiana Petrova, Ludwig Institute, Switzerland:
Mechanisms of lymphatic vascular specialisation
Karina Yaniv, Weizmann Institute, Israel:
Lymphatic vessels in embryonic development
Hong Chen, Harvard Medical School:
Lymphatics in cardiovascular and metabolic diseases
Pilhan Kim, KAIST, Daejeon, Korea
Mariona Graupera, Barcelona, Spain:
Lymphangiogenesis in cancer
Benjamin Hogan, University of Melbourne, Australia
Christiana Ruhrberg, University College London, UK:
Developmental origins of lymphatic endothelial cells
Catherine Porcher, University of Oxford, UK:
Lineage tracing of endothelium
Graeme Birdsey, Imperial College London, UK:
Regulation of lymphatic endothelial cell gene expression and lymphangiogenesis by the transcription factor ERG
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders